AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary

• AngioDynamics Inc ANGO reported a quarterly adjusted loss of 3 cents​​ per share for the quarter ended May 31, higher than the same quarter last year, when the company reported EPS of -6 cents. The mean expectation of three analysts for the quarter was for a loss of 12 cents per share. Wall Street expected results to range from -17 cents to -9 cents per share.

• Revenue rose 12.9% to $80.16 million from a year ago; analysts expected $74.26 million.

• AngioDynamics Inc's reported EPS for the quarter was a loss of 15 cents​.

• The company reported a quarterly loss of $6.05 million.

• AngioDynamics Inc shares had fallen by 2.9% this quarter and gained 5.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for AngioDynamics Inc is $16.00, about 39.8% above its last closing price of $9.63

This summary was machine generated from LSEG data July 15 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)